Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, Human) by Type (Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies, Others) by Clinical Trial Phases (Phase 0, Phase I, Phase II, Phase III, Phase IV) by Source (Diagnostic Testing, Autoimmune Diseases, Cancer Treatment (Breast Cancer, Stomach Cancer, Others) Pregnancy Testing, Radioimmunodetection (RID) of Cancer, Radioimmunotheraphy (RIT) of Cancer, Viral Disease Treatment, Identifying Pathogens, Alzheimer’s disease, Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma, Rhesus Disease Immunization, Systemic Lupus Erythematosus, Crohn's Disease, Ulcerative Colitis, Psoriasis and Rheumatoid Arthritis, Cardiovascular Disease, Others) by End Use (Hospitals, Clinics, Research Institutes, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Report ID :AMI-796 | Category : Information & Technology | Published Date : January, 2021 | Pages : 402 | Format :PDF